USE OF COVID-19 ANTIVIRALS IN PATIENTS PREVIOUSLY TREATED WITH TIXAGEVIMAB/CILGAVIMAB PROPHYLAXIS: EXPERIENCE OF AN ITALIAN HOSPITAL.
Autor: | Restivo, I., Galuppi, C., Chiari, F., Casella, C., Penocchio, G., Paganotti, D., Testa, T. E. |
---|---|
Zdroj: | European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA97-A98, 2p |
Databáze: | Supplemental Index |
Externí odkaz: |